Annual Total Debt
$1.03 M
-$3.81 M-78.71%
31 December 2023
Summary:
Enlivex Therapeutics annual total debt is currently $1.03 million, with the most recent change of -$3.81 million (-78.71%) on 31 December 2023. During the last 3 years, it has fallen by -$4.97 million (-82.82%). ENLV annual total debt is now -82.82% below its all-time high of $6.01 million, reached on 31 December 2021.ENLV Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$765.00 K
-$70.00 K-8.38%
30 September 2024
Summary:
Enlivex Therapeutics quarterly total debt is currently $765.00 thousand, with the most recent change of -$70.00 thousand (-8.38%) on 30 September 2024. Over the past year, it has dropped by -$267.00 thousand (-25.87%). ENLV quarterly total debt is now -87.26% below its all-time high of $6.01 million, reached on 31 December 2021.ENLV Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -25.9% |
| 3 y3 years | -82.8% | -87.3% |
| 5 y5 years | +739.0% | +522.0% |
ENLV Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.8% | at low | -87.3% | +21.6% |
| 5 y | 5 years | -82.8% | +739.0% | -87.3% | +542.9% |
| alltime | all time | -82.8% | -87.3% |
Enlivex Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $765.00 K(-8.4%) |
| June 2024 | - | $835.00 K(-10.0%) |
| Mar 2024 | - | $928.00 K(-10.1%) |
| Dec 2023 | $1.03 M(-78.7%) | $1.03 M(-77.2%) |
| Sept 2023 | - | $4.52 M(+3.4%) |
| June 2023 | - | $4.37 M(-6.6%) |
| Mar 2023 | - | $4.68 M(-3.5%) |
| Dec 2022 | $4.85 M(-19.3%) | $4.85 M(-7.9%) |
| Sept 2022 | - | $5.26 M(+736.2%) |
| June 2022 | - | $629.00 K(-9.4%) |
| Mar 2022 | - | $694.00 K(-88.4%) |
| Dec 2021 | $6.01 M(+2858.6%) | $6.01 M(+844.3%) |
| Sept 2021 | - | $636.00 K(+202.9%) |
| June 2021 | - | $210.00 K(+2.4%) |
| Mar 2021 | - | $205.00 K(+1.0%) |
| Dec 2020 | $203.00 K(+65.0%) | $203.00 K(-70.2%) |
| Sept 2020 | - | $682.00 K(+90.0%) |
| June 2020 | - | $359.00 K(+201.7%) |
| Mar 2020 | - | $119.00 K(-3.3%) |
| Dec 2019 | $123.00 K(>+9900.0%) | $123.00 K(>+9900.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00 |
| Dec 2012 | $0.00(0.0%) | - |
| Dec 2002 | $0.00(0.0%) | - |
| Dec 2001 | $0.00(0.0%) | - |
| Dec 2000 | $0.00(0.0%) | - |
| Dec 1999 | $0.00(0.0%) | - |
| Dec 1998 | $0.00(0.0%) | - |
| Dec 1997 | $0.00 | - |
FAQ
- What is Enlivex Therapeutics annual total debt?
- What is the all time high annual total debt for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly total debt year-on-year change?
What is Enlivex Therapeutics annual total debt?
The current annual total debt of ENLV is $1.03 M
What is the all time high annual total debt for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total debt is $6.01 M
What is Enlivex Therapeutics quarterly total debt?
The current quarterly total debt of ENLV is $765.00 K
What is the all time high quarterly total debt for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total debt is $6.01 M
What is Enlivex Therapeutics quarterly total debt year-on-year change?
Over the past year, ENLV quarterly total debt has changed by -$267.00 K (-25.87%)